AIM Projected Dividend Yield
AIM ImmunoTech Inc ( AMEX : AIM )AIM ImmunoTech is an immuno-pharma company that is focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases and immune-deficiency disorders. Co.'s primary pharmaceutical product platform consists of Ampligen® and Alferon N Injection®. Ampligen is approved for sale in Argentina for severe Chronic Fatigue Syndrome (CFS) and is an experimental drug in the U.S. undergoing clinical development for the treatment of certain cancers and myalgic encephalomyelitis/CFS. Alferon N Injection is a natural alpha interferon for the intralesional treatment of refractory or recurring external genital warts in patients 18 years of age or older. 20 YEAR PERFORMANCE RESULTS |
AIM Dividend History Detail AIM Dividend News AIM Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |